Impact of hormone receptor status and tumor subtypes on clinical behavior and outcomes of breast cancer in young BRCA carriers

被引：0

作者：

Arecco, Luca

Bruzzone, Marco

Hamy, Anne-Sophie

Kim, Hee Jeong

Di Meglio, Antonio

Bernstein-Molho, Rinat

Hilbers, Florentine

Pogoda, Katarzyna

Carrasco, Estela

Punie, Kevin

Bajpai, Jyoti

Agostinetto, Elisa

Lopetegui-Lia, Nerea

Partridge, Ann H.

Phillips, Kelly-Anne

Toss, Angela

Rousset-Jablonski, Christine

Curigliano, Giuseppe

Blondeaux, Eva

Lambertini, Matteo

机构：

[1] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Sch Med, Genoa, Italy

[2] Hop Univ Bruxelles HUB, Acad Trials Promoting Team, Inst Jules Bordet, Brussels, Belgium

[3] IRCCS Osped Policlin San Martino, UO Epidemiol Clin, Genoa, Italy

[4] Univ Paris Cite, Dept Med Oncol, Inst Curie, Paris, France

[5] Univ Ulsan, Div Breast Surg, Dept Surg, Asan Med Ctr,Coll Med, Seoul, South Korea

[6] Gustave Roussy, Canc Survivorship Program, INSERM 981, Villejuif, France

[7] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Danek Gertner Inst Human Genet, Tel Hashomer, Israel

[8] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands

[9] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland

[10] Inst Oncol, Warsaw, Poland

[11] Vall dHebron Univ Hosp, Hereditary Canc Genet Unit, VHIO, Dept Med Oncol, Barcelona, Spain

[12] Univ Hosp, Dept Gen Med Oncol, Leuven, Belgium

[13] Univ Hosp, Multidisciplinary Breast Ctr, Leuven Canc Inst, Leuven, Belgium

[14] Tata Mem Hosp, Mumbai, India

[15] ULB, HUB, ATPT, Brussels, Belgium

[16] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA

[17] Dana Farber Canc Inst, Boston, MA USA

[18] Univ Melbourne, Dept Med Oncol, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[19] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[20] Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Melbourne, Vic, Australia

[21] Univ Hosp Modena, Dept Haematol & Oncol, Modena, Italy

[22] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy

[23] Claude Bernard Lyon 1 Univ, Dept Surg, Ctr Leon Berard, Unite INSERM U1290 RESHAPE, Lyon, France

[24] IRCCS, European Inst Oncol, Milan, Italy

[25] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[26] IRCCS Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy

[27] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Sch Med, Genoa, Italy

[28] IRCCS Osped Policlin San Martino, UOC Clin Oncol Med, Dept Med Oncol, Genoa, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

504

引用

页数：1

共 50 条

[21] Clinical outcomes according to BRCA status in breast cancer patients: Can the BRCA mutation be used as a prognostic factor for breast cancer?
Hong, Sunghoon
Kim, Sungyong
Han, Sunwook
Lee, Jongeun
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 484 - 485
[22] The Impact of Stage and Molecular Subtypes on Survival Outcomes in Young Women with Breast Cancer
Hariharan, Nisha
Rao, T. Subramanyeshwar
Naidu, Chandra K.
Raju, K. V. V. N.
Rajappa, Senthil
Ayyagari, Santa
Krishnamohan, M. V. T.
Murthy, Sudha
Suryadevara, Aparna
Boleneni, Naren
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2019, 8 (05) : 628 - 634
[23] Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
Shirdarreh, Melika
Pezo, Rossanna C.
BREAST CANCER, 2021, 28 (03) : 755 - 764
[24] Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review
Melika Shirdarreh
Rossanna C. Pezo
Breast Cancer, 2021, 28 : 755 - 764
[25] Impact of BRCA mutation status on the clinical phenotype and survival of hereditary breast cancer
Kiechle, M.
Engel, C.
Schmutzler, R.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[26] Impact of BRCA mutation status on the clinical phenotype and survival of hereditary breast cancer
Kiechle, M.
Engel, C.
Schwarz-Boeger, U.
Grund, D.
Preisler-Adams, S.
Crohns, C.
Stark, S.
Gadzicki, D.
Strunz, K.
Schoenbuchner, I
Nestle-Kraeemeling, C.
Kast, K.
Ditsch, N.
Schlehe, B.
Schmutzler, R.
CANCER RESEARCH, 2009, 69 (02) : 229S - 229S
[27] Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
Jon G Jonasson
Olafur A Stefansson
Oskar T Johannsson
Helgi Sigurdsson
Bjarni A Agnarsson
Gudridur H Olafsdottir
Kristin K Alexiusdottir
Hrefna Stefansdottir
Rodrigo Munoz Mitev
Katrin Olafsdottir
Kristrun Olafsdottir
Adalgeir Arason
Vigdis Stefansdottir
Elinborg J Olafsdottir
Rosa B Barkardottir
Jorunn E Eyfjord
Steven A Narod
Laufey Tryggvadóttir
British Journal of Cancer, 2016, 115 : 776 - 783
[28] Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
Jonasson, Jon G.
Stefansson, Olafur A.
Johannsson, Oskar T.
Sigurdsson, Helgi
Agnarsson, Bjarni A.
Olafsdottir, Gudridur H.
Alexiusdottir, Kristin K.
Stefansdottir, Hrefna
Mitev, Rodrigo Munoz
Olafsdottir, Katrin
Olafsdottir, Kristrun
Arason, Adalgeir
Stefansdottir, Vigdis
Olafsdottir, Elinborg J.
Barkardottir, Rosa B.
Eyfjord, Jorunn E.
Narod, Steven A.
Tryggvadottir, Laufey
BRITISH JOURNAL OF CANCER, 2016, 115 (07) : 776 - 783
[29] Physical Activity in Young BRCA Carriers and Reduced Risk of Breast Cancer
Bucy, Ana M.
Valencia, Celina I.
Howe, Carol L.
Larkin, Tyler J.
Conard, Kelly D.
Anderlik, Eric W.
Valdivi, Sarah I.
Bea, Jennifer W.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2022, 63 (05) : 837 - 845
[30] Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy
Wang, Tingting
Wang, Jinnan
Zhao, Wei
Pan, Yueyin
CLINICAL BREAST CANCER, 2024, 24 (05) : e370 - e378.e1

← 1 2 3 4 5 →